(2026). Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Correction: Impact of Bictegravir/emtricitabine/tenofovir Alafenamide on Health-related Quality of Life and Economic Outcomes in HIV Care: Substudy of the BIC-NOW Clinical Trial."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Correction: Impact of Bictegravir/emtricitabine/tenofovir Alafenamide on Health-related Quality of Life and Economic Outcomes in HIV Care: Substudy of the BIC-NOW Clinical Trial."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.